Research Library

The authors sought to develop and test a tool that accurately predicts the unique financial burden to individual patients undergoing treatment for breast cancer. JCO Clinical Cancer Informatics, an American Society of Clinical Oncology Journal

Environmental disasters impact disadvantaged communities disproportionately both through the epidemiological challenge of exposure, but also by undermining the progress of public health efforts.

This study leverages validated patient-reported outcomes measures  to analyze the association between "financial toxicity" and quality of life and satisfaction among women undergoing ablative breast cancer surgery. Journal of the American College of Surgeons

The authors aim to construct a value-based care framework for reconstructive surgery using post-mastectomy reconstruction as an organizing element. Breast Cancer Research and Treatment.

By Morgan N. Fredell, Hagop M. Kantarjian, Ya-Chen Shih, Vivian Ho and Binata Mukherjee Current U.S. health care spending includes many areas of wasted expenditures. In this study, published in Cancer, the authors explore plans to optimize U.S. health care to provide greater benefits to patients: https://bit.ly/2TmeoDg

The authors examine the relationship between market competition and the use of surgical services for cancer to test the theory that market competition promotes patient access and health care delivery.

The authors examine adherence to treatment guidelines for colon cancer among elderly patients in Texas.

Higher costs for complex cancer surgery may be an indicator for worse, rather than better, quality of care, according to new research by the Baker Institute and the University of Texas MDAnderson Cancer Center. The study suggests that lower patient costs achieved by high-volume surgeons can be explained by the lower occurrence of “processes of care”— many of which are taken to avoid or treat complications that can occur during surgery, such as placing arterial lines or providing epidural anesthesia.

As his term progresses, President Trump will be faced with a large number of policy challenges, some of them requiring immediate science & technology expertise. In this Science Magazine article, the authors urge the president to consider the Office of Science & Technology Policy, the science advisor and the presidential S&T councils as vital resources that should be used early in the term to drive his policy agenda.

Little is known about regional variation in cancer treatment and its determinants. In this publication, authors compare rates of adherence to treatment guidelines for elderly patients across Texas and whether local specialist supply is an important determinant of treatment variation.